March 18: The Week in Cancer News
Metastatic prostate cancer incidence rose after recommendation against routine screening, and FDA approves first PARP inhibitor for early-stage breast...
Progress Against Cancer
Metastatic prostate cancer incidence rose after recommendation against routine screening, and FDA approves first PARP inhibitor for early-stage breast...
A new report from the American Association for Cancer Research explores how the COVID-19 pandemic affected cancer patients, researchers...
A new kind of blood test could help detect brain tumors at an earlier stage.
Results favor Enhertu for treating metastatic breast cancer that recurs or does not respond to first-line treatment.
Seven immune checkpoint inhibitors, targeting the PD-1, PD-L1, or CTLA-4 proteins, are currently approved for the treatment of cancer....
Metastatic cancer patients nearing death continue to receive high-dose radiation despite guidelines advising against it, and new standards are...
Each year in the United States, about 14,480 women are diagnosed with cervical cancer, and about 4,290 women die of...
Women with breast cancer who choose fertility preservation have treatment outcomes similar to women who don’t undergo fertility preservation.
Researchers aim to minimize disease relapses by targeting multiple proteins.
The year 2021 defied our expectations in a variety of ways. The delta and omicron COVID-19 variants imposed unprecedented...